Overview
Glossopharyngeal neuralgia (GPN), also known as Weisenburg syndrome or vagoglossopharyngeal neuralgia, is a rare pain disorder characterized by severe, paroxysmal episodes of sharp, stabbing, or electric shock-like pain in the areas innervated by the glossopharyngeal nerve (cranial nerve IX) and sometimes the vagus nerve (cranial nerve X). The pain typically affects the back of the throat, tonsillar region, base of the tongue, ear canal, and occasionally the angle of the jaw. Episodes are usually brief, lasting seconds to a few minutes, but can be excruciating. Pain attacks are commonly triggered by swallowing, chewing, talking, coughing, yawning, or touching the affected areas. In some cases, GPN can be associated with bradycardia, hypotension, or even syncope (fainting) and cardiac arrest due to involvement of the vagus nerve, a potentially life-threatening complication known as vagoglossopharyngeal neuralgia with syncope. The condition primarily affects the nervous system and can be classified as classical (idiopathic), where no structural cause is identified but neurovascular compression of the glossopharyngeal nerve root is often suspected, or secondary (symptomatic), where an identifiable lesion such as a tumor, vascular malformation, or elongated styloid process (Eagle syndrome) is present. GPN most commonly presents in adults, typically after the age of 40, and appears to be slightly more common in men. Treatment of glossopharyngeal neuralgia typically begins with pharmacological management using anticonvulsant medications such as carbamazepine or oxcarbazepine, which are often effective in reducing the frequency and severity of pain episodes. Gabapentin and pregabalin may also be used. For patients who do not respond adequately to medication or who experience intolerable side effects, surgical options are available, including microvascular decompression (MVD) of the glossopharyngeal nerve, which has shown high success rates, or rhizotomy (sectioning of the nerve). In cases with cardiac complications, a cardiac pacemaker may be considered as an adjunctive measure. Early diagnosis and appropriate management are important to prevent potentially dangerous cardiovascular complications.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
1 eventBeijing Tiantan Hospital
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableCARBAMAZEPINE
Beneficial results have also been reported in glossopharyngeal neuralgia
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Glossopharyngeal neuralgia.
Community
No community posts yet. Be the first to share your experience with Glossopharyngeal neuralgia.
Start the conversation →Latest news about Glossopharyngeal neuralgia
No recent news articles for Glossopharyngeal neuralgia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Glossopharyngeal neuralgia
What is Glossopharyngeal neuralgia?
Glossopharyngeal neuralgia (GPN), also known as Weisenburg syndrome or vagoglossopharyngeal neuralgia, is a rare pain disorder characterized by severe, paroxysmal episodes of sharp, stabbing, or electric shock-like pain in the areas innervated by the glossopharyngeal nerve (cranial nerve IX) and sometimes the vagus nerve (cranial nerve X). The pain typically affects the back of the throat, tonsillar region, base of the tongue, ear canal, and occasionally the angle of the jaw. Episodes are usually brief, lasting seconds to a few minutes, but can be excruciating. Pain attacks are commonly trigge
How is Glossopharyngeal neuralgia inherited?
Glossopharyngeal neuralgia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Glossopharyngeal neuralgia typically begin?
Typical onset of Glossopharyngeal neuralgia is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Glossopharyngeal neuralgia?
Yes — 1 recruiting clinical trial is currently listed for Glossopharyngeal neuralgia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Glossopharyngeal neuralgia?
25 specialists and care centers treating Glossopharyngeal neuralgia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.